Navigation

Published technology appraisals

This table lists published NICE technology appraisals. The list can be sorted by title (alphabetically), issue date and review date. You can also:

  • click the appraisal title for full details
  • click a column heading to sort the list by that column

Please note that the 'review date' is not the date when a review of it the appraisal starts, but the date NICE consults on a proposal for reviewing it. There is no guarantee that at the review date, a review will be undertaken. Appraisals which have been considered for review and where the decision has been not to carry out a review at this time are listed in static technology appraisals.

More information on the published appraisals list.

For technology appraisal guidance organised by category, use Find guidance in the main header area above.

Searching for specific technology appraisal guidance?

Published appraisals

Results 141-160 of 311

Ref Title Date Issued Review
TA141 Rheumatoid arthritis (refractory) - abatacept (TA141) (replaced by TA195) Apr 2008 Jul 2010
TA142 Anaemia (cancer-treatment induced) - erythropoietin (alfa and beta) and darbepoetin (TA142) May 2008 TBC
TA143 Ankylosing spondylitis - adalimumab, etanercept and infliximab (TA143) May 2008 TBC
TA144 Obesity - rimonabant (withdrawn) (TA144) (withdrawn) Jun 2008 Apr 2010
TA145 Head and neck cancer - cetuximab (TA145) Jun 2008 TBC
TA146 Psoriasis - adalimumab (TA146) Jun 2008 Jul 2008
TA147 Breast cancer (advanced & metastatic) - bevacizumab (withdrawn) (TA147) Jun 2008 TBC
TA148 Lung cancer (non-small-cell) - bevacizumab (terminated appraisal) (TA148) Jun 2008 TBC
TA149 Glioma (recurrent) - carmustine implants (terminated appraisal) (TA149) Jun 2008 TBC
TA150 Colorectal cancer (metastatic) - cetuximab (terminated appraisal) (TA150) (replaced by TA242) Jun 2008 TBC
TA151 Diabetes - insulin pump therapy (TA151) Jul 2008 TBC
TA152 Coronary artery disease - drug-eluting stents (TA152) Jul 2008 TBC
TA153 Hepatitis B - entecavir (TA153) Aug 2008 Mar 2012
TA154 Hepatitis B - telbivudine (TA154) Aug 2008 Mar 2012
TA155 Macular degeneration (age-related) - ranibizumab and pegaptanib (TA155) Aug 2008 Feb 2014
TA156 Pregnancy (rhesus negative women) - routine anti-D (review) (TA156) Aug 2008 TBC
TA157 Venous thromboembolism - dabigatran (TA157) Sep 2008 TBC
TA158 Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir (TA158) Sep 2008 Sep 2011
TA159 Pain (chronic neuropathic or ischaemic) - spinal cord stimulation (TA159) Oct 2008 Nov 2011
TA160 Osteoporosis - primary prevention (TA160) Jan 2011 Jul 2010

This page was last updated: 23 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.